Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Molecular Cytogenetics Market?
In recent years, the market size of molecular cytogenetics has seen robust growth. The market is set to expand from $2.85 billion in 2024 to $3.12 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.5%. The surge observed in the historical period could be ascribed to an increase in the instances of genetic disorders and cancer, a burgeoning demand for tailored medicine, advancements in life science research and development, the application of clinical tests for prenatal and postnatal diagnosis, and worldwide efforts promoting genomic medicine.
What Growth Rate Is Forecasted for the Molecular Cytogenetics Market by 2029?
Rapid expansion is expected for the molecular cytogenetics market in the upcoming years. It’s projected to reach a value of “$4.67 billion in 2029, increasing at a compound annual growth rate (CAGR) of 10.6%. Factors contributing to this estimated growth in the given forecast period include the advent of next-generation sequencing (NGS), an increased emphasis on liquid biopsies, a surge in its use in cancer research, broader applications in diagnosing infectious diseases, and a rapid increase in genetic testing services. In the pipeline for the forecast period are developments like next-generation sequencing (NGS) in cytogenetics, automation, large-scale screening, advancements in fluorescence in situ hybridization (fish), a growing application in cancer diagnosis, and single-cell analysis.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10096&type=smp
Which Key Companies Are Shaping the Future of the Molecular Cytogenetics Market?
Major companies operating in the molecular cytogenetics market include Abbott Laboratories, Agilent Technologies Inc, Applied Spectral Imaging, CytoTest Inc, Danaher Corporation, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Oxford Gene Technology Limited, Affymetrix Inc, NeoGenomics Laboratories Inc, Quest Diagnostics, F. Hoffmann-La Roche AG, Bi Biological industries, Cytognomix Inc, Empire Genomics LLC., Genial Genetic Solutions Ltd., BioChain Institute Inc., BioGenex Laboratories Inc., Bio-Techne Corporation, Cytocell Ltd., Kreatech Diagnostics B.V., Leica Biosystems Nussloch GmbH, MetaSystems Group Holding GmbH, MolecularMD Corporation, Natera Inc., Opko Health Inc., PathGroup Inc., Roche Diagnostics Corporation, SciGene Corporation, SkylineDx B.V.
Which Factors Are Driving Demand in the Molecular Cytogenetics Industry?
The surge in genetic diseases and cancer is foreseen to propel the expansion of the molecular cytogenetics market. Cancer is a disease characterized by the rampant growth and spread of the body’s cells. Inspecting samples of blood and tissue through cytogenetic tests aids in determining changes in chromosomes, such as broken, missing, or rearranged ones. Distinct changes in chromosomes suggest the presence of a genetic illness, specific conditions, or specific cancer types. Consequently, the rising prevalence of genetic diseases and cancer is anticipated to fuel market growth. To illustrate, the American Cancer Society, a voluntary health organization based in the United States, predicts that by 2040, the global load will rise to 27.5 million new cancer cases and 16.3 million cancer-related deaths. Moreover, in 2022, there were 1,918,030 new cancer cases and 609,360 cancer deaths in the United States, with around 350 deaths due to lung cancer daily. Thus, the escalating occurrence of genetic diseases and cancer is powering the growth of the molecular cytogenetics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=10096&type=smp
How Is the Molecular Cytogenetics Market Segmented by Several Divisions?
The molecular cytogenetics market covered in this report is segmented –
1) By Product: Instruments, Kits And Reagents, Software, Services, Consumables Or Accessories
2) By Technology: Comparative Genomic Hybridization, Fluorescence In Situ Hybridization, Immunohistochemistry, Karyotyping, Other Technologies
3) By Application: Genetic Disorders, Cancer, Personalized Medicines, Other Applications
4) By End-User: Clinical And Research Laboratories, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Other End-Users
Subsegments:
1) By Instruments: Fluorescence In Situ Hybridization (FISH) Systems, Microarray Platforms, Next-Generation Sequencing (NGS) Instruments, Chromatography Systems, Imaging Systems
2) By Kits And Reagents: DNA Extraction Kits, RNA Isolation Kits, PCR Kits, Hybridization Kits, Staining Kits
3) By Software: Data Analysis Software, Image Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Reporting Software
4) By Services: Custom Research Services, Technical Support Services, Consulting Services, Training Services, Quality Control Services
5) By Consumables Or Accessories: Pipettes And Tips, Reagent Plates, Glass Slides And Coverslips, Sample Storage Containers, Assay Plates
What are the Emerging Market Trends Driving the Growth of the Molecular Cytogenetics Industry?
Leading businesses in the molecular cytogenetics market are concentrating their efforts on launching innovative solutions such as cytogenetic diagnostics, to boost the precision of the diagnosis. The principle behind cytogenetic diagnostics involves the assessment of chromosomes and their individual structures to pinpoint genetic diseases, chromosomal anomalies, and associated conditions through approaches like karyotyping and fluorescence in situ hybridization (FISH). For instance, the CCMB (Centre for Cellular and Molecular Biology), a research institute located in India, in July 2023, initiated the use of optical genome mapping, an advanced method for genetic testing. This cutting-edge technology augments genetic diagnostic capabilities by facilitating a high-resolution examination of genomes, crucial in detecting structural variations in DNA potentially linked to diverse genetic disorders.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/molecular-cytogenetics-global-market-report
Which Regions Are Driving Growth in the Molecular Cytogenetics Market?
North America was the largest region in the molecular cytogenetics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global molecular cytogenetics market report during the forecast period. The regions covered in the molecular cytogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10096
This Report Delivers Insight On:
1. How big is the molecular cytogenetics market, and how is it changing globally?
2. Who are the major companies in the molecular cytogenetics market, and how are they performing?
3. What are the key opportunities and risks in the molecular cytogenetics market right now?
4. Which products or customer segments are growing the most in the molecular cytogenetics market?
5. What factors are helping or slowing down the growth of the molecular cytogenetics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
